GGrantIndex
← Leaderboards

Bruce Furie

Beth Israel Deaconess Medical Center

$39,376,853
Attributed
$40,625,338
Total exposure
21
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $7.1M · FY200519
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19

Funding mix

By agency

NIH$51,748,596 · 22

By mechanism

U54$22,246,516 · 8
R01$12,634,471 · 6
P01$10,776,757 · 4
T32$5,898,562 · 1
S10$175,395 · 1
R13$15,000 · 1

Top collaborators

Most similar at Beth Israel Deaconess Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “Thrombosis

Research focus

ThrombosisBlood CoagulationIntravital MicroscopyProtein Disulfide IsomeraseThrombusFibrinBlood PlateletsThromboplastinIn VivoHemostatic FunctionBlood VesselsVenousEvaluationProteinsPreventInhibitor/AntagonistGenerationsMortality Vital StatisticsMouse ModelProgramsPlatelet ActivationLaboratoriesEndothelial CellsDesign

Grant awards (101)

Vascular Thiol Isomerases in Thrombosis$821,996
R01 · FY2019 · HL · contact PI
Vascular Thiol Isomerases in Thrombosis$826,269
R01 · FY2018 · HL · contact PI
Vascular Thiol Isomerases in Thrombosis$848,706
R01 · FY2017 · HL · contact PI
Protein disulfide isomerases: A new class of antithrombotic targets$2,268,467
U54 · FY2016 · HL · contact PI
PDI inhibition to prevent thrombosis in humans$564,261
U54 · FY2016 · HL · contact PI
Identification and characterization of novel antithrombotic PDI inhibitors$462,509
U54 · FY2016 · HL · contact PI
PDl: Function in thrombus formation and antithrombotic action of inhibitors in m$417,646
U54 · FY2016 · HL · contact PI
Intravital Microscopy and Animal$288,037
U54 · FY2016 · HL · contact PI
Molecular and Structural Biology$203,102
U54 · FY2016 · HL · contact PI
Translational Research Skills Development$186,503
U54 · FY2016 · HL · contact PI
Administrative$146,409
U54 · FY2016 · HL · contact PI
FASEB SRC on Functional Disulfide Bonds in Health and Disease$15,000
R13 · FY2016 · HL · contact PI
Protein disulfide isomerases: A new class of antithrombotic targets$2,229,976
U54 · FY2015 · HL · contact PI
PDI inhibition to prevent thrombosis in humans$574,914
U54 · FY2015 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$542,252
T32 · FY2015 · HL · contact PI
Identification and characterization of novel antithrombotic PDI inhibitors$451,550
U54 · FY2015 · HL · contact PI
PDl: Function in thrombus formation and antithrombotic action of inhibitors in m$409,744
U54 · FY2015 · HL · contact PI
Intravital Microscopy and Animal$279,383
U54 · FY2015 · HL · contact PI
Molecular and Structural Biology$195,569
U54 · FY2015 · HL · contact PI
Translational Research Skills Development$179,192
U54 · FY2015 · HL · contact PI
Administrative$139,624
U54 · FY2015 · HL · contact PI
Protein disulfide isomerases: A new class of antithrombotic targets$2,247,088
U54 · FY2014 · HL · contact PI
PDI inhibition to prevent thrombosis in humans$576,154
U54 · FY2014 · HL · contact PI
Identification and characterization of novel antithrombotic PDI inhibitors$451,960
U54 · FY2014 · HL · contact PI
PDl: Function in thrombus formation and antithrombotic action of inhibitors in m$413,718
U54 · FY2014 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$349,824
T32 · FY2014 · HL · contact PI
Intravital Microscopy and Animal$281,468
U54 · FY2014 · HL · contact PI
Molecular and Structural Biology$198,469
U54 · FY2014 · HL · contact PI
Translational Research Skills Development$182,249
U54 · FY2014 · HL · contact PI
Administrative$143,070
U54 · FY2014 · HL · contact PI
Protein disulfide isomerases: A new class of antithrombotic targets$2,113,568
U54 · FY2013 · HL · contact PI
PDI inhibition to prevent thrombosis in humans$543,852
U54 · FY2013 · HL · contact PI
Identification and characterization of novel antithrombotic PDI inhibitors$424,456
U54 · FY2013 · HL · contact PI
PDl: Function in thrombus formation and antithrombotic action of inhibitors in m$389,025
U54 · FY2013 · HL · contact PI
Intravital Microscopy and Animal$264,334
U54 · FY2013 · HL · contact PI
Molecular and Structural Biology$186,386
U54 · FY2013 · HL · contact PI
Translational Research Skills Development$171,155
U54 · FY2013 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$135,573
T32 · FY2013 · HL · contact PI
Administrative$134,360
U54 · FY2013 · HL · contact PI
Protein disulfide isomerases: A new class of antithrombotic targets$2,264,159
U54 · FY2012 · HL · contact PI
Thrombus Formation In Vivo$1,734,969
P01 · FY2012 · HL · contact PI
PDI inhibition to prevent thrombosis in humans$614,148
U54 · FY2012 · HL · contact PI
Identification and characterization of novel antithrombotic PDI inhibitors$445,854
U54 · FY2012 · HL · contact PI
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles$420,750
R01 · FY2012 · HL · contact PI
PDl: Function in thrombus formation and antithrombotic action of inhibitors in m$409,786
U54 · FY2012 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$375,123
T32 · FY2012 · HL · contact PI
Intravital Microscopy and Animal$277,664
U54 · FY2012 · HL · contact PI
Molecular and Structural Biology$195,785
U54 · FY2012 · HL · contact PI
Translational Research Skills Development$179,787
U54 · FY2012 · HL · contact PI
Administrative$141,135
U54 · FY2012 · HL · contact PI
Thrombus Formation In Vivo$1,752,196
P01 · FY2011 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$512,755
T32 · FY2011 · HL · contact PI
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles$425,000
R01 · FY2011 · HL · contact PI
Thrombus Formation In Vivo$1,750,347
P01 · FY2010 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$504,966
T32 · FY2010 · HL · contact PI
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles$425,000
R01 · FY2010 · HL · contact PI
Thrombus Formation In Vivo$1,749,170
P01 · FY2009 · HL · contact PI
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles$425,000
R01 · FY2009 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$401,104
T32 · FY2009 · HL · contact PI
Thrombus Formation In Vivo$1,799,864
P01 · FY2008 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$447,572
T32 · FY2008 · HL · contact PI
Cancer, venous thromboembolic disease and tissue factor-bearing microparticles$425,000
R01 · FY2008 · HL · contact PI
Factor lXa-Factor Vllla complexes in blood coagulation$402,977
R01 · FY2008 · HL · contact PI
SELECTIN LIGANDS IN LEUKOCYTE BIOLOGY AND INFLAMMATION$402,977
R01 · FY2008 · HL · contact PI
Factor lXa-Factor Vllla complexes in blood coagulation$402,977
R01 · FY2007 · HL · contact PI
SELECTIN LIGANDS IN LEUKOCYTE BIOLOGY AND INFLAMMATION$402,977
R01 · FY2007 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$1
T32 · FY2007 · HL · contact PI
Program in Blood Coagulation and Vascular Biology$447,572
T32 · FY2006 · HL · contact PI
Factor lXa-Factor Vllla complexes in blood coagulation$415,013
R01 · FY2006 · HL · contact PI
SELECTIN LIGANDS IN LEUKOCYTE BIOLOGY AND INFLAMMATION$415,013
R01 · FY2006 · HL · contact PI
SELECTIN LIGANDS IN LEUKOCYTE BIOLOGY AND INFLAMMATION$425,000
R01 · FY2005 · HL
Factor lXa-Factor Vllla complexes in blood coagulation$425,000
R01 · FY2005 · HL
Program in Blood Coagulation and Vascular Biology$147,572
T32 · FY2005 · HL
Program in Blood Coagulation and Vascular Biology$447,572
T32 · FY2004 · HL
Role of selectins and selectin ligands in the pathobiol*$425,000
R01 · FY2004 · HL
Factor lXa-Factor Vllla complexes in blood coagulation$425,000
R01 · FY2004 · HL
SELECTIN LIGANDS IN LEUKOCYTE BIOLOGY AND INFLAMMATION$425,000
R01 · FY2004 · HL
GAMMA GLUTAMYL CARBOXYLASE FROM MARINE INVERTEBRATES$1,895
P41 · FY2004 · RR
PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGY$440,663
T32 · FY2003 · HL
Role of selectins and selectin ligands in the pathobiol*$425,000
R01 · FY2003 · HL
PLATELET CELL ADHESION MOLECULES$382,887
R01 · FY2003 · HL
Role of selectins and selectin ligands in the pathobiol*$425,000
R01 · FY2002 · HL
PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGY$373,589
T32 · FY2002 · HL
PLATELET CELL ADHESION MOLECULES$372,590
R01 · FY2002 · HL
CORE--ANALYTICAL$186,685
P01 · FY2002 · HL
CORE--CELL CULTURE, MONOCLONAL AND ANIMAL$186,685
P01 · FY2002 · HL
FACTOR IX COMPLEXES ON MEMBRANE SURFACES$186,685
P01 · FY2002 · HL
Role of selectins and selectin ligands in the pathobiol*$425,000
R01 · FY2001 · HL
PLATELET CELL ADHESION MOLECULES$412,229
R01 · FY2001 · HL
PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGY$402,439
T32 · FY2001 · HL
BIOSYNTHESIS OF BLOOD CLOTTING PROTEINS$307,928
R01 · FY2001 · HL
CORE--ANALYTICAL$186,685
P01 · FY2001 · HL
FACTOR IX COMPLEXES ON MEMBRANE SURFACES$186,685
P01 · FY2001 · HL
CORE--CELL CULTURE, MONOCLONAL AND ANIMAL$186,685
P01 · FY2001 · HL
INTRAVITAL VIDEO-RATE CONFOCAL MICROSCOPE$175,395
S10 · FY2001 · RR
PLATELET CELL ADHESION MOLECULES$400,224
R01 · FY2000 · HL
PROGRAM IN BLOOD COAGULATION AND VASCULAR BIOLOGY$369,985
T32 · FY2000 · HL
BIOSYNTHESIS OF BLOOD CLOTTING PROTEINS$298,958
R01 · FY2000 · HL
CORE--CELL CULTURE, MONOCLONAL AND ANIMAL$290,035
P01 · FY2000 · HL
FACTOR IX COMPLEXES ON MEMBRANE SURFACES$290,033
P01 · FY2000 · HL
CORE--ANALYTICAL$290,033
P01 · FY2000 · HL